Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.
Phase 2
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000000817
- Lead Sponsor
- agasaki Thoracic Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1) Massive pleural effusion 2) Massivepericardial effusion 3) Interstitial pneumonitis 4) Uncontrolled brain metastasis 5) Active infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate, time to progression, toxicity
- Secondary Outcome Measures
Name Time Method